BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zeng X, Ward SE, Zhou J, Cheng ASL. Liver Immune Microenvironment and Metastasis from Colorectal Cancer-Pathogenesis and Therapeutic Perspectives. Cancers (Basel) 2021;13:2418. [PMID: 34067719 DOI: 10.3390/cancers13102418] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Mödl B, Moritsch S, Zwolanek D, Eferl R. Type I and II interferon signaling in colorectal cancer liver metastasis. Cytokine 2023;161:156075. [DOI: 10.1016/j.cyto.2022.156075] [Reference Citation Analysis]
2 He Y, Han Y, Fan AH, Li D, Wang B, Ji K, Wang X, Zhao X, Lu Y. Multi-perspective comparison of the immune microenvironment of primary colorectal cancer and liver metastases. J Transl Med 2022;20:454. [PMID: 36195882 DOI: 10.1186/s12967-022-03667-2] [Reference Citation Analysis]
3 Lee S, Hwang S, Son C. CGX, a standardized herbal syrup, inhibits colon-liver metastasis by regulating the hepatic microenvironments in a splenic injection mouse model. Front Pharmacol 2022;13:906752. [DOI: 10.3389/fphar.2022.906752] [Reference Citation Analysis]
4 Chandra R, Karalis JD, Liu C, Murimwa GZ, Voth Park J, Heid CA, Reznik SI, Huang E, Minna JD, Brekken RA. The Colorectal Cancer Tumor Microenvironment and Its Impact on Liver and Lung Metastasis. Cancers (Basel) 2021;13:6206. [PMID: 34944826 DOI: 10.3390/cancers13246206] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 11.0] [Reference Citation Analysis]
5 Herrero A, Knetemann E, Mannaerts I. Review: Challenges of In Vitro CAF Modelling in Liver Cancers. Cancers (Basel) 2021;13:5914. [PMID: 34885024 DOI: 10.3390/cancers13235914] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]